Home›Screener›TYRA›Profile
C
59/100

Tyra Biosciences

TYRAPrecision Medicine
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Tyra Biosciences (TYRA) is the lead sponsor of 7 active clinical trials listed on ClinicalTrials.gov[3], including 4 Phase 2[1], 4 Phase 1[2].

TYRA has 3 Form 4 insider filings recorded at the SEC in the past 30 days[4].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. SEC EDGAR · 0001863127 (2026-04-11) ↗
🔬
Clinical Trials
7
NCT05544552Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor, Urothelial Carcinoma, Solid Tumor, Adult, Bladder Cancer, Non-muscle-invasive Bladder Cancer, FGFR3 Gene Mutation, FGFR3 Gene Alteration, Advanced Solid Tumor, Advanced Urothelial Carcinoma, Urinary Tract Cancer, Urinary Tract Tumor, Urinary Tract Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06006702Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06160752Locally Advanced Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Solid Tumor, Metastatic Cholangiocarcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06842355Achondroplasia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06915753Metastatic Hepatocellular Carcinoma, Solid Tumors, Solid Tumor, Adult, FGFR Gene Amplification, FGFR Gene Alterations, FGFR3 Gene Alteration, FGFR3 Gene Mutation, Advanced Solid Tumors, FGFR4 Gene Mutation, FGFR4 Gene Fusions, FGF19 Gene Amplification, FGF19 Gene Overexpression, FGFR3 Gene Fusions, Locally Advanced Unresectable Hepatocellular Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06995677Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations, FGFR3 Gene Alteration, FGFR3 Gene Mutation, FGFR3 Gene Fusions
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07265947Low Grade Upper Tract Urothelial Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
3 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials5
Sector Peers (Precision Medicine)
COGTCogent Biosciences
D
Data Provenance
cik1 verified
clinical trial7 verified
insider buy1 verified
trial count3 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR